Xtant Medical Holdings, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 2007, the company has established itself as a leader in the development and distribution of innovative spinal and cranial surgical solutions. With a focus on regenerative medicine, Xtant Medical offers a range of core products, including allograft tissue and advanced surgical instruments, designed to enhance patient outcomes. Operating primarily in North America, Xtant Medical has achieved significant milestones, including strategic acquisitions that have expanded its product portfolio and market reach. Renowned for its commitment to quality and innovation, the company continues to strengthen its position in the competitive landscape of orthopaedic and neurosurgical markets, making it a trusted partner for healthcare professionals worldwide.
How does Xtant Medical Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Xtant Medical Holdings, Inc.'s score of 20 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Xtant Medical Holdings, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Xtant Medical Holdings, Inc. does not inherit emissions data from any parent or related organisations, meaning all information is self-reported. The company has not established any Science-Based Targets Initiative (SBTi) commitments or other industry-standard climate initiatives. In the context of the medical device industry, where sustainability and climate commitments are increasingly important, Xtant Medical Holdings, Inc. may need to consider developing a comprehensive strategy to address carbon emissions and set measurable reduction targets in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Xtant Medical Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
